Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE)
Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE)
Sponsor: Gynesonics
Terminated
Termination due to continued lack of patient compliance
Other terminated trials from Gynesonics
More terminations from Gynesonics
Other Uterine Fibroid trials with similar outcome
Listed as NCT03118037, this observational or N/A phase trial focuses on Uterine Fibroid and remains terminated or withdrawn. Sponsored by Gynesonics, it has been updated 17 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
17 versions recorded-
Sep 2025 — Present [monthly]
Terminated
-
Jan 2025 — Sep 2025 [monthly]
Terminated
Status: Recruiting → Terminated
-
Sep 2024 — Jan 2025 [monthly]
Recruiting
-
Aug 2024 — Sep 2024 [monthly]
Recruiting
-
Jul 2024 — Aug 2024 [monthly]
Recruiting
▶ Show 12 earlier versions
-
Sep 2023 — Jul 2024 [monthly]
Recruiting
-
Mar 2023 — Sep 2023 [monthly]
Recruiting
-
Sep 2021 — Mar 2023 [monthly]
Recruiting
Status: Suspended → Recruiting
-
Mar 2021 — Sep 2021 [monthly]
Suspended
Status: Recruiting → Suspended
-
Jan 2021 — Mar 2021 [monthly]
Recruiting
-
Feb 2020 — Jan 2021 [monthly]
Recruiting
-
Oct 2019 — Feb 2020 [monthly]
Recruiting
-
Aug 2018 — Oct 2019 [monthly]
Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jul 2017 — Apr 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2017 — Jul 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Gynesonics
For direct contact, visit the study record on ClinicalTrials.gov .